Haemodynamic, hormonal, and electrolyte effects of enalapril in heart failure.

Enalapril, the new converting enzyme inhibitor, was administered to eight patients with heart failure (NYHA Functional Class II to IV) during standardised and intensive haemodynamic, hormone, and electrolyte monitoring. The first dose (5 mg) of enalapril induced a fall in plasma angiotensin II and n...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Br Heart J
Hauptverfasser:	Fitzpatrick, D, Nicholls, M G, Ikram, H, Espiner, E A
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMJ Publishing Group 1983
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC481390/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6309203/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.50.2.163
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!